SCHEMBL186897

SCHEMBL186897

Cl/C1=C/CC/C=C\CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL895275 1.00
SCHEMBL1771877 0.97
SCHEMBL31154658 0.97
SCHEMBL31252519 0.97
SCHEMBL289691 0.97
SCHEMBL1771875 0.97
SCHEMBL289692 0.97
SCHEMBL3619266 0.97
SCHEMBL3265617 0.97
SCHEMBL30170485 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 251 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025060714-A1 METAL COMPLEX, PREPARATION METHOD THEREFOR, USE THEREOF, AND PREPARATION METHOD FOR OLEFIN COPOLYMER 中国石油天然气股份有限公司 2025-03-27 WO claimed
EP-4355732-A1 PROCESS FOR PREPARING PEXIDARTINIB Johnson Matthey Public Limited Company (GB) 2024-04-24 EP claimed
CN-117466940-A Cyperus rotundus L ligand and application thereof in preparation of chiral beta-butyrolactone 万华化学集团股份有限公司 2024-01-30 CN claimed
CN-117377657-A Method for preparing pexidasatinib 庄信万丰股份有限公司 2024-01-09 CN claimed
CN-117185884-A Synthesis method of (R) -4-substituted hexahydropyrimidine compound 四川大学 2023-12-08 CN claimed
CN-116751234-A Ligand compound with dual responsiveness, preparation method thereof, catalyst and application 中国科学技术大学 2023-09-15 CN claimed
CN-116731084-A Ligand compound with metal ion regulation and control function, catalyst and preparation method 中国科学技术大学 2023-09-12 CN claimed
WO-2022263801-A1 PROCESS FOR PREPARING PEXIDARTINIB JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2022-12-22 WO claimed
EP-1926776-B1 USE OF A RUBBER COMPOUND AS A MATERIAL IN THE INSERTION AREA OF FUEL CELLS FREUDENBERG CARL KG (DE) 2012-11-14 EP claimed
EP-0626402-B1 Linear telechelic difunctional polymers and process for their preparation. CALIFORNIA INST OF TECHN (US) 2002-07-31 EP claimed
EP-0857183-B1 PROCESS FOR PREPARATION OF ADDITION PRODUCTS OF DIFUNCTIONAL TELECHELIC POLYOLEFINS FROM CYCLIC OLEFINS BY OLEFIN METATHESIS REACTION CALIFORNIA INST OF TECHN (US) 2001-11-07 EP claimed
US-6143851-A Process for preparation of addition products of difunctional telechelic polyolefins from cyclic olefins by olefin metathesis reaction BP AMOCO CORPORATION (US) 2000-11-07 US claimed
EP-0857183-A1 PROCESS FOR PREPARATION OF ADDITION PRODUCTS OF DIFUNCTIONAL TELECHELIC POLYOLEFINS FROM CYCLIC OLEFINS BY OLEFIN METATHESIS REACTION AMOCO CORPORATION (US) 1998-08-12 EP claimed
US-5731383-A USED FOR HIGH DENSITY POLYESTERS, POLYAMIDES, POLYUREAS, POLYURETHANES AMOCO CORPORATION (US) 1998-03-24 US claimed
WO-1998006771-A1 PROCESS FOR PREPARATION OF ADDITION PRODUCTS OF DIFUNCTIONAL TELECHELIC POLYOLEFINS FROM CYCLIC OLEFINS BY OLEFIN METATHESIS REACTION AMOCO CORPORATION (US) 1998-02-19 WO claimed
US-5621047-A CATALYTIC CROSS-METATHESIS REACTION OF OLEFINS WITH ALKYL (METH)ACRYLATES YIELDS PURE, UNSATURATED POLYMERS HAVING REACTIVE END GROUPS AMOCO CORPORATION (US) 1997-04-15 US claimed
US-5589548-A Process for preparing difunctional telechelic linear non-crosslinked polyolefins AMOCO CORPORATION (US) 1996-12-31 US claimed
US-5512635-A OLEFIN METATHESIS PROCESS; CROSSLINKING INHIBITION AMOCO CORPORATION (US) 1996-04-30 US claimed
EP-0626402-A2 Process for preparing linear monofunctional and telechelic difunctional polymers and compositions obtained thereby AMOCO CORPORATION (US) 1994-11-30 EP claimed
US-20260132234-A1 COPOLYMER AND METHOD FOR DECOMPOSING COPOLYMER BRIDGESTONE CORPORATION (JP) 2026-05-14 US disclosed
US-20260001846-A1 SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS SERVIER LAB (FR) 2026-01-01 US disclosed
US-20250276315-A1 COVALENTLY MODIFIED SURFACES, KITS, AND METHODS OF PREPARATION AND USE BRUKER SPATIAL BIOLOGY, INC. 2025-09-04 US disclosed
EP-4610291-A1 COPOLYMER, AND METHOD FOR DECOMPOSING COPOLYMER BRIDGESTONE CORPORATION (JP) 2025-09-03 EP disclosed
CN-116731084-B Ligand compound with metal ion regulation and control function, catalyst and preparation method 中国科学技术大学 2025-06-17 CN disclosed
EP-4551566-A1 NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS Les Laboratoires Servier (FR) 2025-05-14 EP disclosed
US-12280370-B2 Covalently modified surfaces, kits, and methods of preparation and use BRUKER CELLULAR ANALYSIS, INC. (US) 2025-04-22 US disclosed
CN-119816491-A New spirocyclohexane derivatives, pharmaceutical compositions containing them and their use as anti-apoptotic inhibitors 法国施维雅药厂 2025-04-11 CN disclosed
WO-2025060714-A1 METAL COMPLEX, PREPARATION METHOD THEREFOR, USE THEREOF, AND PREPARATION METHOD FOR OLEFIN COPOLYMER 中国石油天然气股份有限公司 2025-03-27 WO disclosed
CN-118239990-B Complex of rare noble metal and chiral phosphine for asymmetric hydrogenation catalytic synthesis of medicine 北京元延医药科技股份有限公司 2025-03-14 CN disclosed
CN-119173511-A Benzotriazole compounds 第一三共株式会社 2024-12-20 CN disclosed
CN-118993843-A Process for producing diol 大金工业株式会社 2024-11-22 CN disclosed
US-20240375097-A1 COVALENTLY MODIFIED SURFACES, KITS, AND METHODS OF PREPARATION AND USE BRUKER SPATIAL BIOLOGY, INC. 2024-11-14 US disclosed
CN-113966324-B NOTCH signaling pathway inhibitors and their use in cancer treatment 塞莱斯蒂亚生物技术股份公司 2024-09-03 CN disclosed
US-20240239793-A1 PROCESS FOR PREPARING PEXIDARTINIB JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2024-07-18 US disclosed
CN-118239990-A Complex of rare noble metal and chiral phosphine for asymmetric hydrogenation catalytic synthesis of medicine 北京元延医药科技股份有限公司 2024-06-25 CN disclosed
EP-4366831-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2024-05-15 EP disclosed
WO-2024090034-A1 COPOLYMER, AND METHOD FOR DECOMPOSING COPOLYMER 株式会社ブリヂストン 2024-05-02 WO disclosed
WO-2024090035-A1 METHOD FOR PRODUCING COPOLYMER, AND COPOLYMER 株式会社ブリヂストン 2024-05-02 WO disclosed
EP-3463665-B1 MICROFLUIDIC DEVICE WITH COVALENTLY MODIFIED SURFACES BRUKER CELLULAR ANALYSIS INC (US) 2024-05-01 EP disclosed
EP-4355732-A1 PROCESS FOR PREPARING PEXIDARTINIB Johnson Matthey Public Limited Company (GB) 2024-04-24 EP disclosed
US-20240109871-A1 ANTI-VIRAL COMPOUNDS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2024-04-04 US disclosed
WO-2024054851-A1 MACROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USING THEREOF SIONNA THERAPEUTICS (US) 2024-03-14 WO disclosed
CN-112119075-B Condensed ring compound 豪夫迈·罗氏有限公司 2024-03-12 CN disclosed
CN-117466940-A Cyperus rotundus L ligand and application thereof in preparation of chiral beta-butyrolactone 万华化学集团股份有限公司 2024-01-30 CN disclosed
WO-2024008941-A1 NEW SPIROCYCLOHEXANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USES AS ANTI-APOPTOTIC INHIBITORS LES LABORATOIRES SERVIER (FR) 2024-01-11 WO disclosed
CN-117377657-A Method for preparing pexidasatinib 庄信万丰股份有限公司 2024-01-09 CN disclosed
US-11851422-B2 Anti-viral compounds ALIGOS THERAPEUTICS, INC. 2023-12-26 US disclosed
CN-117185884-A Synthesis method of (R) -4-substituted hexahydropyrimidine compound 四川大学 2023-12-08 CN disclosed
WO-2023210740-A1 BENZOTHIOPHENE COMPOUND 第一三共株式会社 2023-11-02 WO disclosed
WO-2023210741-A1 BENZOTRIAZOLE COMPOUND 第一三共株式会社 2023-11-02 WO disclosed
US-11801508-B2 Covalently modified surfaces, kits, and methods of preparation and use Berkeley Lights, Inc. (US) 2023-10-31 US disclosed
CN-116783183-A 1- (2- (4-cyclopropyl-1H-1, 2, 3-triazol-1-yl) acetyl) -4-hydroxy-N- (benzyl) pyrrolidine-2-carboxamide derivatives as VHL inhibitors for the treatment of anemia and cancer 基因泰克公司 2023-09-19 CN disclosed
CN-116751234-A Ligand compound with dual responsiveness, preparation method thereof, catalyst and application 中国科学技术大学 2023-09-15 CN disclosed
CN-116731084-A Ligand compound with metal ion regulation and control function, catalyst and preparation method 中国科学技术大学 2023-09-12 CN disclosed
US-11712680-B2 Process for reducing aromatic nitro compounds with supported catalyst KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2023-08-01 US disclosed
US-20230093249-A1 ANTI-VIRAL COMPOUNDS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-03-23 US disclosed
US-20230072083-A1 SYSTEM AND METHOD FOR SCREENING OF PROTEIN-LIGAND INTERACTIONS USING PARA-HYDROGEN POLARIZATION AND NMR NATIONAL SCIENCE FOUNDATION 2023-03-09 US disclosed
WO-2023021080-A1 CHEMICAL PROCESS FOR VINYL ETHER SYNTHESIS HENKEL AG & CO. KGAA (DE) 2023-02-23 WO disclosed
WO-2023021081-A1 VINYL ETHERS HENKEL AG & CO. KGAA (DE) 2023-02-23 WO disclosed
EP-4137485-A1 VINYL ETHERS Henkel AG & Co. KGaA (DE) 2023-02-22 EP disclosed
EP-4137475-A1 CHEMICAL PROCESS FOR VINYL ETHER SYNTHESIS Henkel AG & Co. KGaA (DE) 2023-02-22 EP disclosed
CN-115678773-A Covalently modified surface, kit, preparation method and application 伯克利之光生命科技公司 2023-02-03 CN disclosed
US-20230024995-A1 NRF2-ACTIVATING COMPOUND SENJU PHARMACEUTICAL CO., LTD. (JP) 2023-01-26 US disclosed
WO-2023283256-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2023-01-12 WO disclosed
US-20220401927-A1 PROCESS FOR REDUCING AROMATIC NITRO COMPOUNDS WITH SUPPORTED CATALYST KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2022-12-22 US disclosed
WO-2022263801-A1 PROCESS FOR PREPARING PEXIDARTINIB JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2022-12-22 WO disclosed
WO-2022226667-A1 SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 WO disclosed
CN-109689213-B Covalently modified surface, kit, preparation method and application 伯克利之光生命科技公司 2022-10-14 CN disclosed
US-11447484-B2 Cyclic compound having dopamine D3 receptor antagonistic effect SHIONOGI & CO., LTD. (JP) 2022-09-20 US disclosed
US-11389464-B2 Arginase inhibitors as therapeutics MARS, INCORPORATED (US) 2022-07-19 US disclosed
CN-113072549-B Method for synthesizing tetrahydroberberine and derivatives thereof 四川大学 2022-06-10 CN disclosed
US-20220169670-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2022-06-02 US disclosed
CN-114315725-A Method for introducing tertiary isopentenyl group to position N2 of indazole 中国科学院大连化学物理研究所 2022-04-12 CN disclosed
US-11186802-B2 Process for the decarboxylation, isomerization, hydrogenation, dehydrogenation and cyclization aromatization of fatty acids yielding products with significant aromatic content THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) 2021-11-30 US disclosed
US-20210238136-A1 AZETIDINE DERIVATIVE, AND PRODRUG THEREOF DAIICHI SANKYO COMPANY, LIMITED (JP) 2021-08-05 US disclosed
EP-3805203-A1 AZETIDINE DERIVATIVE, AND PRODRUG THEREOF Daiichi Sankyo Company, Limited (JP) 2021-04-14 EP disclosed
US-20210032565-A1 Process for the Decarboxylation, Isomerization, Hydrogenation, Dehydrogenation and Cyclization Aromatization of Fatty Acids Yielding Products with Significant Aromatic Content THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE 2021-02-04 US disclosed
EP-3719024-A1 ARGINASE INHIBITORS AS THERAPEUTICS Mars, Incorporated (US) 2020-10-07 EP disclosed
US-20200298212-A1 IRON OXIDE SUPPORTED RHODIUM CATALYST FOR NITROARENE REDUCTION KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2020-09-24 US disclosed
US-20200255423-A1 INHIBITORS OF TYROSINE KINASE 2 MEDIATED SIGNALING ABBVIE INC (US) 2020-08-13 US disclosed
US-20200246362-A1 Arginase Inhibitors as Therapeutics MARS, INCORPORATED 2020-08-06 US disclosed
EP-3433254-B1 NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS GLAXOSMITHKLINE IP DEV LTD (GB) 2020-06-17 EP disclosed
EP-3034509-B1 ARGINASE INHIBITORS AS THERAPEUTICS MARS INC (US) 2020-04-22 EP disclosed
US-10603330-B2 Arginase inhibitors as therapeutics MARS, INCORPORATED (US) 2020-03-31 US disclosed
WO-2019178079-A9 INHIBITORS OF TYROSINE KINASE 2 MEDIATED SIGNALING ABBVIE INC. (US) 2019-12-12 WO disclosed
WO-2019178079-A1 INHIBITORS OF TYROSINE KINASE 2 MEDIATED SIGNALING ABBVIE INC. (US) 2019-09-19 WO disclosed
EP-3539966-A1 INHIBITORS OF TYROSINE KINASE 2 MEDIATED SIGNALING AbbVie Inc. (US) 2019-09-18 EP disclosed
US-20190276450-A1 INHIBITORS OF TYROSINE KINASE 2 MEDIATED SIGNALING ABBVIE INC. 2019-09-12 US disclosed
US-10399932-B2 Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer BRISTOL-MYERS SQUIBB COMPANY (US) 2019-09-03 US disclosed
US-10399933-B2 Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancer BRISTOL-MYERS SQUIBB COMPANY (US) 2019-09-03 US disclosed
US-20190112306-A1 NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-04-18 US disclosed
US-20190054101-A1 ARGINASE INHIBITORS AS THERAPEUTICS MARS, INCORPORATED 2019-02-21 US disclosed
EP-3433254-A1 NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS GlaxoSmithKline Intellectual Property Development Limited (GB) 2019-01-30 EP disclosed
EP-2560978-B1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS MARS INC (US) 2019-01-30 EP disclosed
US-10167254-B2 IDO inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2019-01-01 US disclosed
US-10098902-B2 Arginase inhibitors as therapeutics MARS, INCORPORATED (US) 2018-10-16 US disclosed
US-20180251479-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS MARS, INCORPORATED 2018-09-06 US disclosed
US-9994594-B2 Inhibitors of arginase and their therapeutic applications MARS, INCORPORATED (US) 2018-06-12 US disclosed
US-20180079712-A1 INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER BRISTOL MYERS SQUIBB CO (US) 2018-03-22 US disclosed
US-20180072660-A1 INHIBITORS OF INDOLEAMINE-2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER BRISTOL MYERS SQUIBB CO (US) 2018-03-15 US disclosed
EP-2758413-B1 IRIDIUM CONTAINING HYDROSILYLATION CATALYSTS AND COMPOSITIONS CONTAINING THE CATALYSTS DOW CORNING (US) 2018-03-07 EP disclosed
EP-3277670-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER Bristol-Myers Squibb Company (US) 2018-02-07 EP disclosed
EP-3277671-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER Bristol-Myers Squibb Company (US) 2018-02-07 EP disclosed
EP-3277672-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER Bristol-Myers Squibb Company (US) 2018-02-07 EP disclosed
WO-2017162570-A1 NAPHTHYRIDINES AS INTEGRIN ANTAGONISTS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-09-28 WO disclosed
US-20170231999-A1 IDO INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-08-17 US disclosed
EP-3186264-A1 ELECTROLUMINESCENT IMIDAZO-QUINOXALINE CARBENE METAL COMPLEXES UDC Ireland Limited (IE) 2017-07-05 EP disclosed
US-20170183362-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS MARS, INCORPORATED 2017-06-29 US disclosed
EP-2308829-B1 A PROCESS FOR PREPARING R-BETA-AMINO PHENYLBUTYRIC ACID DERIVATIVES JIANGSU HENGRUI MEDICINE CO (CN) 2017-06-14 EP disclosed
WO-2017044043-A1 PROCESS FOR DIRECT AMIDATION OF AMINES VIA RH(I)-CATALYZED ADDITION OF BOROXINES AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-03-16 WO disclosed
WO-2017044043-A1 PROCESS FOR DIRECT AMIDATION OF AMINES VIA RH(I)-CATALYZED ADDITION OF BOROXINES AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2017-03-16 WO disclosed
US-20170000808-A1 ARGINASE INHIBITORS AS THERAPEUTICS MARS, INCORPORATED 2017-01-05 US disclosed
EP-2768491-B1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS MARS INC (US) 2016-12-21 EP disclosed
EP-2852598-B3 RING CONSTRAINED ANALOGS AS ARGINASE INHIBITORS MARS INC (US) 2016-10-19 EP disclosed
CN-106008569-A Boronates as arginase inhibitors, compositions and applications thereof 马尔斯公司 2016-10-12 CN disclosed
WO-2016161286-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER BRISTOL-MYERS SQUIBB COMPANY (US) 2016-10-06 WO disclosed
WO-2016161279-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER BRISTOL-MYERS SQUIBB COMPANY (US) 2016-10-06 WO disclosed
WO-2016161269-A1 INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE FOR THE TREATMENT OF CANCER BRISTOL-MYERS SQUIBB COMPANY (US) 2016-10-06 WO disclosed
US-20160289171-A1 IDO INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2016-10-06 US disclosed
US-9440995-B2 Arginase inhibitors as therapeutics MARS, INCORPORATED (US) 2016-09-13 US disclosed
EP-3034509-A1 ARGINASE INHIBITORS AS THERAPEUTICS Mars, Incorporated (US) 2016-06-22 EP disclosed
US-9303013-B2 Conjugates and associated methods of producing them for the prevention or treatment of nicotine addiction PFIZER INC. (US) 2016-04-05 US disclosed
US-9266908-B2 Inhibitors of arginase and their therapeutic applications MARS, INCORPORATED (US) 2016-02-23 US disclosed
WO-2016020516-A1 ELECTROLUMINESCENT IMIDAZO-QUINOXALINE CARBENE METAL COMPLEXES BASF SE (DE) 2016-02-11 WO disclosed
EP-2632927-B1 BORONATES AS ARGINASE INHIBITORS MARS INC (US) 2016-02-10 EP disclosed
US-20160009697-A1 PYRIDINE DERIVATIVES AS 5-HT6 RECEPTOR ANTAGONISTS SELVITA SA (PL) 2016-01-14 US disclosed
US-9233985-B2 Arginase inhibitors as therapeutics MARS, INCORPORATED (US) 2016-01-12 US disclosed
EP-2958912-A1 PYRIDINE DERIVATIVES AS 5-HT6 RECEPTOR ANTAGONISTS SELVITA S.A. (PL) 2015-12-30 EP disclosed
US-9221041-B2 Iridium containing hydrosilylation catalysts and compositions containing the catalysts DOW CORNING CORPORATION (US) 2015-12-29 US disclosed
WO-2015160125-A1 NOVEL PREPARATION METHOD OF QUINOLINE N-OXIDE DERIVATIVE WITH AMIDE GROUP INSTITUTE FOR BASIC SCIENCE (KR) 2015-10-22 WO disclosed
US-20150224490-A1 Hydrosilylation Catalysts Made With Terdentate Nitrogen Ligands And Compositions Containing The Catalysts DOW CORNING (US) 2015-08-13 US disclosed
US-20150191492-A1 ARGINASE INHIBITORS AS THERAPEUTICS MARS, INCORPORATED 2015-07-09 US disclosed
US-9040703-B2 Inhibitors of arginase and their therapeutic applications MARS, INCORPORATED (US) 2015-05-26 US disclosed
EP-2509950-B1 5-Amino-4-hydroxypentoyl amides JANSSEN R & D IRELAND (IE) 2015-02-25 EP disclosed
US-20140371175-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS MARS, INCORPORATED 2014-12-18 US disclosed
US-20140343019-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS MARS, INCORPORATED 2014-11-20 US disclosed
CN-102950024-B Catalyst for asymmetric catalytic hydrogenation of imine SINOCHEM CORPORATION (CN) 2014-10-22 CN disclosed
CN-102950025-B Asymmetric hydrogenation catalyst of imine and its use SINOCHEM CORP 2014-09-10 CN disclosed
WO-2014128223-A1 PYRIDINE DERIVATIVES AS 5-HT6 RECEPTOR ANTAGONISTS SELVITA S.A. (PL) 2014-08-28 WO disclosed
EP-2768491-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS Mars, Incorporated (US) 2014-08-27 EP disclosed
US-20140228570-A1 Hydrosilylation Catalysts Made With Terdentate Nitrogen Ligands And Compositions Containing The Catalysts DOW CORNING CORPORATION 2014-08-14 US disclosed
EP-2758413-A1 IRIDIUM CONTAINING HYDROSILYLATION CATALYSTS AND COMPOSITIONS CONTAINING THE CATALYSTS Dow Corning Corporation (US) 2014-07-30 EP disclosed
US-20140206869-A1 Iridium Containing Hydrosilylation Catalysts and Compositions Containing the Catalysts DOW SILICONES CORPORATION 2014-07-24 US disclosed
EP-2721043-A1 METAL COMPLEXES COMPRISING AZABENZIMIDAZOLE CARBENE LIGANDS AND THE USE THEREOF IN OLEDS BASF SE (DE) 2014-04-23 EP disclosed
WO-2014021908-A1 IRIDIUM CONTAINING HYDROSILYLATION CATALYSTS AND COMPOSITIONS CONTAINING THE CATALYSTS DOW CORNING CORPORATION (US) 2014-02-06 WO disclosed
US-8592429-B2 5-amino-4-hydroxypentoyl amides JANSSEN R&D IRELAND (IE) 2013-11-26 US disclosed
US-8580997-B2 Process for preparing R-beta-amino phenylbutyric acid derivatives JIANGSU HENGRUI MEDICINE CO. LTD. (CN) 2013-11-12 US disclosed
EP-2632927-A1 BORONATES AS ARGINASE INHIBITORS Mars, Incorporated (US) 2013-09-04 EP disclosed
WO-2013059437-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS MARS, INCORPORATED (US) 2013-04-25 WO disclosed
WO-2013043826-A1 TRICYCLIC COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS ABBVIE INC. (US) 2013-03-28 WO disclosed
US-20130072470-A1 NOVEL TRICYCLIC COMPOUNDS ABBVIE INC. (US) 2013-03-21 US disclosed
CN-102950024-A Catalyst for asymmetric catalytic hydrogenation of imine SINOCHEM CORP 2013-03-06 CN disclosed
CN-102950025-A Asymmetric hydrogenation catalyst of imine and its use SINOCHEM CORP 2013-03-06 CN disclosed
EP-2560978-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS Mars, Incorporated (US) 2013-02-27 EP disclosed
WO-2012172482-A1 METAL COMPLEXES COMPRISING AZABENZIMIDAZOLE CARBENE LIGANDS AND THE USE THEREOF IN OLEDS BASF SE (DE) 2012-12-20 WO disclosed
US-20120295920-A1 5-AMINO-4-HYDROXYPENTOYL AMIDES JANSSEN SCIENCES IRELAND UC (IE) 2012-11-22 US disclosed
EP-2509950-A1 5-AMINO- 4-HYDROXYPENTOYL AMIDES Janssen R&D Ireland (IE) 2012-10-17 EP disclosed
US-20120129806-A1 ARGINASE INHIBITORS AS THERAPEUTICS MARS, INCORPORATED 2012-05-24 US disclosed
WO-2012058065-A1 BORONATES AS ARGINASE INHIBITORS MARS INCORPORATED (US) 2012-05-03 WO disclosed
US-20120083469-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS MARS, INCORPORATED 2012-04-05 US disclosed
EP-2401269-A1 INDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS Merck Sharp & Dohme Corp. (US) 2012-01-04 EP disclosed
WO-2011133653-A1 INHIBITORS OF ARGINASE AND THEIR THERAPEUTIC APPLICATIONS MARS, INCORPORATED (US) 2011-10-27 WO disclosed
WO-2011070131-A1 5-AMINO- 4-HYDROXYPENTOYL AMIDES TIBOTEC PHARMACEUTICALS (IE) 2011-06-16 WO disclosed
WO-2011068881-A1 NOVEL TRICYCLIC COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-09 WO disclosed
US-20110130587-A1 PROCESS FOR PREPARING R-BETA-AMINO PHENYLBUTYRIC ACID DERIVATIVES JIANGSU HENGRUI MEDICINE CO., LTD. (CN) 2011-06-02 US disclosed
US-7947425-B2 Fluorinated vinyl ethers, copolymers thereof, and use in lithographic photoresist compositions INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2011-05-24 US disclosed
EP-2308829-A1 A PROCESS FOR PREPARING R-BETA-AMINO PHENYLBUTYRIC ACID DERIVATIVES Jiangsu Hengrui Medicine Co., Ltd. (CN) 2011-04-13 EP disclosed
WO-2010099039-A1 INDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2010-09-02 WO disclosed
US-7635739-B2 Substantially linear polymers and methods of making and using same ROHM AND HAAS COMPANY (US) 2009-12-22 US disclosed
CN-100569859-C Comprise the rubber composition of undressed aluminium hydroxide as filler WACKER CHEMIE GMBH SOC (DE) 2009-12-16 CN disclosed
US-7511110-B2 Crosslinkable polyorganosiloxane compositions WACKER CHEMIE AG (DE) 2009-03-31 US disclosed
CN-100451072-C Polysiloxane rubber composition having improved durability WACKER CHEMIE GMBH SOC (DE) 2009-01-14 CN disclosed
US-7465837-B2 The monomer: 3-Hydroxy-3,3-bis(trifluoromethyl)-2-methylpropyl vinyl ether; for preparing chemical amplification resists that are transparent to deep ultraviolet radiation used in the manufacture of integrated circuits INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2008-12-16 US disclosed
CN-100404622-C Crosslinkable polyorganosiloxane compositions WACKER CHEMIE AG (DE) 2008-07-23 CN disclosed
US-7385000-B2 Silicone rubber composition having improved storage stability WACKER CHEMIE AG (DE) 2008-06-10 US disclosed
EP-1647579-B1 Silicone rubber composition with prolonged potlife WACKER CHEMIE AG (DE) 2007-12-26 EP disclosed
US-7265158-B2 Non-metal aerogel materials and detectors, liquid and gas absorbing objects, and optical devices comprising same BROWN UNIVERSITY RESEARCH FOUNDATION (US) 2007-09-04 US disclosed
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1672031-B1 Crosslinkable polyorganosiloxane compositions WACKER CHEMIE AG (DE) 2007-03-21 EP disclosed
US-20070049712-A1 Substantially Linear Polymers and Methods of Making and Using Same ROHM AND HAAS COMPANY (US) 2007-03-01 US disclosed
EP-1647578-B1 Silicone rubber composition comprising an aluminum hydroxide filler being not surface treated WACKER CHEMIE AG (DE) 2007-02-21 EP disclosed
CN-1294208-C Organic polyorganosiloxane modulation agent capable of solidifying WACKER CHEMIE GMBH (DE) 2007-01-10 CN disclosed
US-20060287558-A1 The monomer: 3-Hydroxy-3,3-bis(trifluoromethyl)-2-methylpropyl vinyl ether; for preparing chemical amplification resists that are transparent to deep ultraviolet radiation used in the manufacture of integrated circuits INTERNATIONAL BUSINESS MACHINES (US) 2006-12-21 US disclosed
US-7150957-B2 Fluorinated vinyl ethers, copolymers thereof, and use in lithographic photoresist compositions INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2006-12-19 US disclosed
US-7147701-B2 Printing medium comprising aerogel materials BROWN UNIVERSITY RESEARCH FOUNDATION (US) 2006-12-12 US disclosed
US-20060275701-A1 Fluorinated vinyl ethers, copolymers thereof, and use in lithographic photoresist compositions INTERNATIONAL BUSINESS MACHINES (US) 2006-12-07 US disclosed
US-20060135689-A1 Crosslinkable polyorganosiloxane compositions WACKER CHEMIE GMBH (DE) 2006-06-22 US disclosed
EP-1672031-A1 Crosslinkable polyorganosiloxane compositions Wacker Chemie AG (DE) 2006-06-21 EP disclosed
CN-1789339-A Crosslinkable polyorganosiloxane compositions WACKER CHEMIE AG (DE) 2006-06-21 CN disclosed
US-7037366-B2 Printing medium comprising aerogel materials BROWN UNIVERSITY RESEARCH FOUNDATION (US) 2006-05-02 US disclosed
US-20060084744-A1 Silicone rubber composition comprising untreated aluminum hydroxide as filler WACKER-CHEMIE GMBH (DE) 2006-04-20 US disclosed
US-20060084745-A1 Silicone rubber composition having improved storage stability WACKER-CHEMIE GMBH (DE) 2006-04-20 US disclosed
EP-1647579-A1 Silicone rubber composition with prolonged potlife Wacker Chemie AG (DE) 2006-04-19 EP disclosed
EP-1647578-A1 Silicone rubber composition comprising an aluminum hydroxide filler being not surface treated Wacker Chemie AG (DE) 2006-04-19 EP disclosed
CN-1760275-A Polysiloxane rubber composition having improved durability WACKER CHEMIE GMBH SOC (DE) 2006-04-19 CN disclosed
CN-1760274-A Silicon rubber composition containing unprocessed aluminium hydroxide as filler WACKER CHEMIE GMBH SOC (DE) 2006-04-19 CN disclosed
WO-2006025809-A1 NON-METAL AEROGEL MATERIALS AND DETECTORS, LIQUID AND GAS ABSORBING OBJECTS, AND OPTICAL DEVICES COMPRISING SAME BROWN UNIVERSITY RESEARCH FOUNDATION (US) 2006-03-09 WO disclosed
CN-1205246-C Process for preparation of addition products of difunctional telechelic polyolefins from cyclic olefins by olefin metathesis reaction CALIFORNIA TECHNOLOGY UNIV (US) 2005-06-08 CN disclosed
EP-1215247-B1 Curable polysiloxane compositions WACKER CHEMIE GMBH (DE) 2005-03-09 EP disclosed
US-20040214102-A1 Fluorinated vinyl ethers, copolymers thereof, and use in lithographic photoresist compositions GLOBALFOUNDRIES U.S. INC. 2004-10-28 US disclosed
US-20040038818-A1 Non-metal aerogel materials and detectors, liquid and gas absorbing objects, and optical devices comprising same BROWN UNIVERSITY RESEARCH FOUNDATION 2004-02-26 US disclosed
US-20030195277-A1 Printing medium comprising aerogel materials RISEN WILLIAM M (US) 2003-10-16 US disclosed
US-20030181569-A1 Printing medium comprising aerogel materials RISEN WILLIAM M (US) 2003-09-25 US disclosed
US-6602336-B2 Aerogel comprising silica, a metal ion, and an organic polymer having having polar functional groups; inks BROWN UNIVERSITY RESEARCH FOUNDATION 2003-08-05 US disclosed
US-6566430-B2 Crosslinking; molding materials WACKER-CHEMIE GMBH (DE) 2003-05-20 US disclosed
US-20020188160-A1 The catalyst either water-soluble or carbon dioxide-soluble and the reaction product soluble in the phase in which the catalyst is insoluble, wherein the reaction products and catalyst can be readily separated by a phase separation LOS ALAMOS NATIONAL SECURITY, LLC 2002-12-12 US disclosed
US-6479708-B1 The catalyst either water-soluble or carbon dioxide-soluble and the reaction product soluble in the phase in which the catalyst is insoluble, wherein the reaction products and catalyst can be readily separated by a phase separation THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-11-12 US disclosed
US-20020111426-A1 Curable organopolysiloxane compositions WACKER-CHEMIE GMBH (DE) 2002-08-15 US disclosed
US-20020111447-A1 Novel end-functionalized polyolefin prepared via ring opening metathesis polymerization in the presence of a novel chain transfer agent, and a process for the preparation of the end-functionalized polyolefin via ring opening metathesis polymerization BAYER CORPORATION 2002-08-15 US disclosed
EP-0626402-B1 Linear telechelic difunctional polymers and process for their preparation. CALIFORNIA INST OF TECHN (US) 2002-07-31 EP disclosed
CN-1358800-A Organic polyorganosiloxane modulation agent capable of solidifying WACKER CHEMIE GMBH (DE) 2002-07-17 CN disclosed
US-20020077428-A1 PROCESS FOR THE SYNTHESIS OF HYDROXYL-END GROUP FUNCTIONALIZED POLYBUTADIENES BAYER CORPORATION 2002-06-20 US disclosed
EP-1215247-A1 Curable polysiloxane compositions Wacker-Chemie GmbH (DE) 2002-06-19 EP disclosed
US-6391978-B1 MIXTURE CONTAINING CHAIN TRANSFER AGENT AND POLYMERIZATION CATALYSTS BAYER CORPORATION 2002-05-21 US disclosed
US-6359098-B1 SHELF LIFE AS ONE-COMPONENT ADDITION-CURABLE ORGANOPOLYSILOXANES, AND EXTENDED POT LIFE FOR TWO-COMPONENT ADDITION-CURABLE ORGANOPOLYSILOXANES, WITHOUT COMPROMISING CROSSLINKING RATES OR LEVELS WACKER-CHEMIE GMBH (DE) 2002-03-19 US disclosed
US-20020016397-A1 Printing medium comprising aerogel materials BROWN UNIVERSITY RESEARCH FOUNDATION 2002-02-07 US disclosed
EP-1077226-B1 Curable Polysiloxane Compositions WACKER CHEMIE GMBH (DE) 2002-01-23 EP disclosed
EP-0857183-B1 PROCESS FOR PREPARATION OF ADDITION PRODUCTS OF DIFUNCTIONAL TELECHELIC POLYOLEFINS FROM CYCLIC OLEFINS BY OLEFIN METATHESIS REACTION CALIFORNIA INST OF TECHN (US) 2001-11-07 EP disclosed
US-6303046-B1 COMPRISING SILICA, AT LEAST ONE POLYMER HAVING A POLAR FUNCTIONAL GROUP, AND AT LEAST ONE METAL-ION-CONTAINING SPECIES; ALCOHOL AND REMAINING LIQUID MAY BE EXTRACTED FROM THE GEL BY SUPERCRITICAL EXTRACTION USING CARBON DIOXIDE. BROWN UNIVERSITY RESEARCH FOUNDATION 2001-10-16 US disclosed
US-6252028-B1 PLATINUM CATALYST WACKER-CHEMIE GMBH (DE) 2001-06-26 US disclosed
EP-0994159-B1 Curable organopolysiloxane composition WACKER CHEMIE GMBH (DE) 2001-04-04 EP disclosed
EP-1077226-A1 Curable Polysiloxane Compositions Wacker-Chemie GmbH (DE) 2001-02-21 EP disclosed
US-6143851-A Process for preparation of addition products of difunctional telechelic polyolefins from cyclic olefins by olefin metathesis reaction BP AMOCO CORPORATION (US) 2000-11-07 US disclosed
US-6060570-A Process for preparation of addition products of difunctional telechelic polyolefins from cyclic olefins by olefin metathesis reaction BP AMOCO CORPORATION (US) 2000-05-09 US disclosed
EP-0994159-A1 Curable organopolysiloxane composition Wacker-Chemie GmbH (DE) 2000-04-19 EP disclosed
CN-1198754-A Process for preparation of addition products of difunctional telechelic polyolefins from cyclic olefins by olefin metathesis reaction AMOCO CORP (US) 1998-11-11 CN disclosed
EP-0857183-A1 PROCESS FOR PREPARATION OF ADDITION PRODUCTS OF DIFUNCTIONAL TELECHELIC POLYOLEFINS FROM CYCLIC OLEFINS BY OLEFIN METATHESIS REACTION AMOCO CORPORATION (US) 1998-08-12 EP disclosed
US-5731383-A USED FOR HIGH DENSITY POLYESTERS, POLYAMIDES, POLYUREAS, POLYURETHANES AMOCO CORPORATION (US) 1998-03-24 US disclosed
WO-1998006771-A1 PROCESS FOR PREPARATION OF ADDITION PRODUCTS OF DIFUNCTIONAL TELECHELIC POLYOLEFINS FROM CYCLIC OLEFINS BY OLEFIN METATHESIS REACTION AMOCO CORPORATION (US) 1998-02-19 WO disclosed
US-5621047-A CATALYTIC CROSS-METATHESIS REACTION OF OLEFINS WITH ALKYL (METH)ACRYLATES YIELDS PURE, UNSATURATED POLYMERS HAVING REACTIVE END GROUPS AMOCO CORPORATION (US) 1997-04-15 US disclosed
US-5616762-A Process for the preparation of 3-halo-and pseudohalo-alkylsilane esters HUELS AKTIENGESELLSCHAFT (DE) 1997-04-01 US disclosed
US-5589548-A Process for preparing difunctional telechelic linear non-crosslinked polyolefins AMOCO CORPORATION (US) 1996-12-31 US disclosed
US-5559190-A Difunctional telechelic linear non-crosslinked polyolefins AMOCO CORPORATION (US) 1996-09-24 US disclosed
US-5512635-A OLEFIN METATHESIS PROCESS; CROSSLINKING INHIBITION AMOCO CORPORATION (US) 1996-04-30 US disclosed
EP-0626402-A2 Process for preparing linear monofunctional and telechelic difunctional polymers and compositions obtained thereby AMOCO CORPORATION (US) 1994-11-30 EP disclosed
WO-1993015092-A1 ORGANOMETALLIC IRIDIUM COMPLEXES HAVING ANTIPARASITIC ACTIVITY UNIVERSITE PARIS SUD XI (FR) 1993-08-05 WO disclosed
US-4219689-A Aromatic hydroalkylation catalyst using iridium on zeolites PHILLIPS PETROLEUM COMPANY (US) 1980-08-26 US disclosed
US-4172932-A Process for the preparation of polymers of cyclopentene or copolymers of cyclopentene with unsaturated alicyclic compounds THE GOODYEAR TIRE & RUBBER COMPANY (US) 1979-10-30 US disclosed
US-4140731-A NORBORNENE COPOLYMER BLEND WITH VINYL CHLORIDE POLYMER SHOWA DENKO KABUSHIKI KAISHA (JP) 1979-02-20 US disclosed
US-4137390-A RING-OPENING, POLYALKENAMERS THE GOODYEAR TIRE & RUBBER COMPANY (US) 1979-01-30 US disclosed
US-4105608-A HIGH IMPACT COMPOSITION OF RING-OPENING POLYMERIZATION PRODUCT SHOWA DENKO K.K. (JP) 1978-08-08 US disclosed
US-4080491-A CATALYST CONTAINS ORGANOMETALLIC COMPOUND AND THE REACTION PRODUCT OF TUNGSTEN OR MOLYBDENUM OXIDE AND A PHOSPHOROUS HALIDE OR OXYHALIDE SHOWA DENKO K.K. (JA) 1978-03-21 US disclosed
US-4059561-A AND A HALOGEN COMPOUND SHOWA DENKO KABUSHIKI KAISHA (JA) 1977-11-22 US disclosed
US-4022954-A ADHESIVES, FLOCCULATING AGENTS, ION EXCHANGE RESINS, MOLDING AGENTS SHOWA DENKO KABUSHIKI KAISHA (JA) 1977-05-10 US disclosed
US-4021510-A HIGH IMPACT STRENGTH SHOWA DENKO KABUSHIKI KAISHA (JA) 1977-05-03 US disclosed
US-4020254-A CATALYTIC POLYMERIZATION THE GOODYEAR TIRE & RUBBER COMPANY (US) 1977-04-26 US disclosed
US-4010113-A TUNGSTEN OR MOLYBDENUM HALIDE- AN ALKYLALUMINUM HALIDE-ALCOHOL THE GOODYEAR TIRE & RUBBER COMPANY (US) 1977-03-01 US disclosed
US-3997471-A TUNGSTEN OR MOLYBDENUM HALIDE OR OXYHALIDE, AN ALKYLALUMINUM HALIDE, ALCOHOL THE GOODYEAR TIRE & RUBBER COMPANY (US) 1976-12-14 US disclosed
US-3991139-A NORBORNENE DERIVATIVES, PHENOLS, ESTER THIOETHERS SHOWA DENKO KABUSHIKI KAISHA (JA) 1976-11-09 US disclosed
US-3945986-A RING OPENING POLYMERIZATION, TUNGSTEN OR MOLYBDENUM HALIDE, ALKYL ALUMINUM HALIDE, ALCOHOL CATALYST THE GOODYEAR TIRE & RUBBER COMPANY (US) 1976-03-23 US disclosed
US-3935179-A TUNGSTEN HALIDE OR OXYHALIDE, AN ALKYL-ALUMINUM HALIDE, ALCOHOL CATALYST THE GOODYEAR TIRE & RUBBER COMPANY (US) 1976-01-27 US disclosed
US-3935179-A TUNGSTEN HALIDE OR OXYHALIDE, AN ALKYL-ALUMINUM HALIDE, ALCOHOL CATALYST THE GOODYEAR TIRE & RUBBER COMPANY (US) 1976-01-27 US disclosed